AM Squared’s MetLife MET Stock Holding History

AM Squared’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,100	Closed	-$62.2K	–	114
2023 Q2	$62.2K	Buy	1,100 +300	+38%	+$16.6K	0.07%	80
2023 Q1	$46.4K	Sell	800 -500	-38%	-$33.7K	0.04%	123
2022 Q4	$94.1K	Buy	+1,300	New	+$93.1K	0.06%	108

Other funds holding MET

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

AM Squared's MET Position: Q3 2023 in Review

AM Squared sold out of MetLife (MET) in Q3 2023, closing a stake of 1,100 shares — an estimated $62.2K sold.

AM Squared first reported a position in MET in Q4 2022 and held it in 3 quarters. The position peaked at $94.1K in Q4 2022. 1,180 funds tracked by Wall St. Rank hold MET as of Q3 2023.

AM Squared reported no remaining MetLife position as of Q3 2023 after selling out during the quarter.
AM Squared sold 1,100 MetLife shares in Q3 2023, an estimated $62.2K.
AM Squared first reported a position in MetLife in Q4 2022 and held it in 3 quarters.
AM Squared's MetLife position peaked at $94.1K in Q4 2022.
1,180 funds tracked by Wall St. Rank held MetLife as of Q3 2023.

Based on AM Squared's 13F filing for Q3 2023, filed 7 Nov 2023.